{
    "eid": "2-s2.0-85167654179",
    "title": "The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Food Science",
            "@code": "1106",
            "@abbrev": "AGRI"
        },
        {
            "@_fa": "true",
            "$": "Nutrition and Dietetics",
            "@code": "2916",
            "@abbrev": "NURS"
        }
    ],
    "keywords": [
        "chitosan oligosaccharide",
        "chronic kidney disease",
        "gut leakage",
        "gut microbiota",
        "maltodextrin",
        "prebiotics",
        "tight junction"
    ],
    "authors": [
        "Weerapat Anegkamol",
        "Panumas Kamkang",
        "Sittiphong Hunthai",
        "Maroot Kaewwongse",
        "Mana Taweevisit",
        "Natthaya Chuaypen",
        "Pakkapon Rattanachaisit",
        "Thasinas Dissayabutra"
    ],
    "citedby-count": 0,
    "ref-count": 53,
    "ref-list": [
        "Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes\u2014A Systematic Review",
        "The Impact of CKD on Uremic Toxins and Gut Microbiota",
        "The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: A randomized controlled trial",
        "The Effect of \u00df-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial",
        "A randomized double-blind cross-over trial to study the effects of resistant starch prebiotic in chronic kidney disease (ReSPECKD)",
        "Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial",
        "Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide",
        "Effects of Prebiotic Therapy on Gastrointestinal Microbiome of Individuals with Different Inflammatory Conditions: A Systematic Review of Randomized Controlled Trials. Probiotics Antimicrob",
        "Decreasing microbiota-derived uremic toxins to improve CKD outcomes",
        "Role of the Gut Microbiota in Children with Kidney Disease",
        "Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota",
        "Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice",
        "Comparative analysis of prebiotic effects of four oligosaccharides using in vitro gut model: Digestibility, microbiome, and metabolome changes",
        "Neural Network-Based Calculator for Rat Glomerular Filtration Rate",
        "Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications",
        "Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro",
        "Prebiotics and Probiotics in Digestive Health",
        "The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model",
        "Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters",
        "Effect of Low-Protein Diet and Inulin on Microbiota and Clinical Parameters in Patients with Chronic Kidney Disease",
        "Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease",
        "Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action",
        "Chitosan: A Natural Biopolymer with a Wide and Varied Range of Applications",
        "Electrosteric stabilization of oil/water emulsions by adsorption of chitosan oligosaccharides\u2014An electrokinetic study",
        "The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives",
        "Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus",
        "Chitosan oligosaccharides, dp 2\u20138, have prebiotic effect on the Bifidobacterium bifidium and Lactobacillus sp",
        "Chitosan and Chitooligosaccharide: The Promising Non-Plant-Derived Prebiotics with Multiple Biological Activities",
        "The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms",
        "Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis",
        "Effects and Mechanisms of Chitosan and ChitosanOligosaccharide on Hepatic Lipogenesis and Lipid Peroxidation, Adipose Lipolysis, and Intestinal Lipid Absorption in Rats with High-Fat Diet-Induced Obesity",
        "CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice",
        "Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis",
        "Antioxidant Capacity and Hepatoprotective Role of Chitosan-Stabilized Selenium Nanoparticles in Concanavalin A-Induced Liver Injury in Mice",
        "Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model",
        "Targeted drug delivery strategy: A bridge to the therapy of diabetic kidney disease",
        "Chitooligosaccharide guanidine inhibits high glucose-induced activation of DAG/PKC pathway by regulating expression of GLUT2 in type 2 diabetic nephropathy rats",
        "Chitosan oligosaccharide alleviates renal fibrosis through reducing oxidative stress damage and regulating TGF-\u03b21/Smads pathway",
        "Novel Potential Application of Chitosan Oligosaccharide for Attenuation of Renal Cyst Growth in the Treatment of Polycystic Kidney Disease",
        "A Novel Resistant Maltodextrin Alters Gastrointestinal Tolerance Factors, Fecal Characteristics, and Fecal Microbiota in Healthy Adult Humans",
        "In healthy adults, resistant maltodextrin produces a greater change in fecal bifidobacteria counts and increases stool wet weight: A double-blind, randomized, controlled crossover study",
        "The Metabolizable Energy of Dietary Resistant Maltodextrin Is Variable and Alters Fecal Microbiota Composition in Adult Men",
        "Resistant Maltodextrin Intake Reduces Virulent Metabolites in the Gut Environment: A Randomized Control Study in a Japanese Cohort",
        "Function of Akkermansia muciniphila in type 2 diabetes and related diseases",
        "Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis. Diabetes Res",
        "Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation",
        "Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: A narrative review",
        "Microbiome-Metabolome Signature of Acute Kidney Injury",
        "Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model",
        "High Red Meat Intake Exacerbates Dextran Sulfate-Induced Colitis by Altering Gut Microbiota in Mice",
        "Effects of Heat Stress on Production Performance, Redox Status, Intestinal Morphology and Barrier-Related Gene Expression, Cecal Microbiome, and Metabolome in Indigenous Broiler Chickens",
        "Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of \u03b1-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats",
        "Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "@id": "60114221",
            "affilname": "University of Phayao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fundamental Fund",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}